With scRNAseq data available in multiple cancer types, we compared expression of genes in EMT and TGF-β signaling pathways in different EC subtypes, fibroblast/myofibroblast subtypes, and tumor cells (Figure 6). This evidence concerns the gene TGFB1 and cancer.